Full-Time

Meeting Supervisor

Speaker Bureau

EVERSANA

EVERSANA

1,001-5,000 employees

Commercial services for pharmaceutical lifecycle management

Compensation Overview

$65k - $95k/yr

Raleigh, NC, USA

Remote

Category
Business & Strategy (1)
Required Skills
Excel/Numbers/Sheets

Get referred to EVERSANA

Find people who can refer or advise you

Requirements
  • Proactive, solution-oriented thinker who anticipates needs, asks thoughtful questions, and takes initiative to address challenges before they escalate.
  • Detail-oriented professional with the ability to manage multiple workstreams, maintain accuracy, and ensure consistency across client deliverables.
  • Education: Bachelor's degree or eight years in a pharmaceutical hospitality role.
  • Experience and/or training: Planning of all types of speaker bureau meetings, live, virtual or hybrid.
  • Technology/Equipment: Proficiency in Zoom and Microsoft Teams; Bureau Platform; Excel excellence; Cvent is preferred but not required.
  • Travel up to 25-30% annually
Responsibilities
  • Attend and participate in new project briefings and kick-off meetings.
  • Provide input, based on knowledge and experience, to support initial budget development for requested meetings.
  • Identify operational improvement opportunities to enhance program execution and drive efficiency.
  • Maintain ongoing dialogue with line management and project teams throughout the project/scope lifecycle to assess progress and initiate scope changes as needed.
  • Develop and maintain a comprehensive understanding of portal functionality, applying strategic thinking to assess, address, and resolve client requests.
  • Attend internal meetings with Client Services, Meeting Services, and key stakeholders, independently collaborating cross-functionally by proactively gathering information, asking the right questions, and driving progress.
  • Support speaker bureau leadership (Director and Senior Director) with reports, strategic and operational presentation development, and training or mentoring of team members.
  • Oversee and support end-to-end program execution for assigned speaker bureau clients, managing all logistics such as venue sourcing, contract negotiations, travel, food and beverage, room sets, audiovisual and production, hotel accommodations, and ground transportation.
  • Independently plan, organize, and execute high-quality virtual meetings with multimedia components, including: Virtual platform configuration; Serving as primary client support; Managing technology/vendors as applicable; Scheduling and executing rehearsals; Attendee management and communications; Providing attendee assistance, connection troubleshooting, and basic technical support during events
  • Ensure program accuracy, attendee management integrity, and adherence to timelines and expectations.
  • Negotiate optimal rates and contract terms with vendors for owned meetings (hotel F&B, audiovisual, transportation, etc.).
  • Maintain the highest standards of quality control for client materials and contribute to best-practice protocols to support project teams.
  • Pivot across multiple speaker bureau clients as needed to support shifting priorities, workload balancing, and business demands.
  • Support coverage for team members during holidays or absences, as required.
  • Maintain client compliance and proactively escalate challenges, risks, or potential issues.
  • Track and prepare accurate attendee spend reports in alignment with Open Payments guidelines.
  • Review, reconcile, and approve final invoices and pass-through costs within required timelines.
  • Ensure ongoing accuracy and financial accountability across all assigned programs.
  • Maintain and/or exceed minimum billable utilization requirements for the role.
  • Demonstrate a commitment to diversity, equity, and inclusion through continuous development, inclusive behaviors, and proactive bias awareness.
  • Provide standard and customized client reports at specified intervals.
  • Perform additional duties as assigned.
Desired Qualifications
  • CMP (Certified Meeting Professional) is preferred but not required

EVERSANA provides integrated commercial services to pharmaceutical and biotech companies across the product lifecycle. It helps with drug pricing, market access, reimbursement, patient adherence, and product delivery through a service-based model. Its solutions are delivered via a global network of 30+ locations, including consulting, market access strategies, patient services, and field deployment. The goal is to help clients bring products to market, optimize pricing and access, improve adherence, and ensure efficient delivery to improve patient outcomes and commercial performance.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Milwaukee, Wisconsin

Founded

2018

Get referred to EVERSANA

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • More than 650 life sciences clients support diversified revenue streams.
  • AI-focused EVERSANA INTOUCH can improve launch execution and marketing efficiency.
  • Partner-led launches for Candel and Xcovery expand scalable pre-commercial services.

What critics are saying

  • PBM incumbents can block Waltz Health adoption through network control.
  • Single-asset launch contracts depend on FDA approvals and launch uptake.
  • Trinity’s APACME acquisition reduces regional capability and local account control.

What makes EVERSANA unique

  • Integrated commercial platform spans pricing, access, adherence, and delivery.
  • Adds market access specialization through Jen Norton’s dedicated business unit.
  • Combines commercialization with Waltz Health’s direct-to-payer purchasing model.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Mental Health Support

Conference Attendance Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
PharmaLive
Feb 12th, 2026
EVERSANA names new chief legal officer

EVERSANA names new chief legal officer. EVERSANA has named Monica Avram as Executive Vice President and Chief Legal Officer, a strategic addition as the company scales operations and reinvents commercialization services. As Chief Legal Officer and a member of the Executive Leadership Team, Monica leads the company's global Legal and Compliance function. Her strategic leadership integrates governance, risk, and operational execution to enable innovation, strengthen enterprise performance, and drive long-term value. With more than two decades of experience at top law firms and across global Fortune 100 companies - including UnitedHealth Group and Sanofi - Avram brings deep expertise at the intersection of healthcare, law, and emerging technologies. She has built high-performing, financially disciplined legal teams, advised executive leadership and boards on enterprise strategy, and guided organizations through complex regulatory and operational environments. "As we continue to scale, it's paramount that we have top talent who can understand the complexity of our industry and bring proven track records of success," said Mark Thierer, CEO, EVERSANA. "Throughout her career, Monica has demonstrated exceptional leadership in building best-in-class legal organizations, and we're thrilled to welcome her to EVERSANA." She brings seasoned board and advisory experience across public companies and nonprofit organizations, with deep expertise in governance, oversight, and strategic leadership. Avram holds a BA in Biology from the University of Missouri - Kansas City and a Juris Doctor from Suffolk University Law School.

Business Wire
Nov 3rd, 2025
Trinity Acquires EVERSANA's APACME Services

Trinity has announced the acquisition of EVERSANA's advisory services operation in the Asia-Pacific and Middle East (APACME) regions. This strategic move will transition EVERSANA's APACME advisory services to Trinity, enhancing its global presence in life sciences commercialization solutions.

PR Newswire
Oct 23rd, 2025
OWP Pharmaceuticals Selects EVERSANA to Support U.S. Launch of SUBVENITE(R)(lamotrigine) Oral Suspension

OWP Pharmaceuticals selects EVERSANA to support U.S. Launch of SUBVENITE(R)(lamotrigine) Oral Suspension. News provided by. CHICAGO, Oct. 23, 2025 /PRNewswire/ - OWP Pharmaceuticals, a privately held, commercial-stage neuroscience specialty pharmaceutical company, today announced that EVERSANA(R), a leading provider of commercialization services to the global life sciences industry, will provide U.S. commercialization services for the launch of SUBVENITE(R)(lamotrigine) oral suspension, the company's novel treatment for epilepsy and bipolar disorders. SUBVENITE(R), approved by the U.S. Food and Drug Administration on September 16, 2025, is the first and only FDA-approved lamotrigine oral suspension in the U.S. It is designed to help improve access to epilepsy treatments as a flexible, patient-friendly alternative to tablets. Lamotrigine is widely prescribed, but is now available in a ready-to-use liquid version. SUBVENITE(R) Oral Suspension is ideal for patients who have difficulty swallowing tablets, those who require individualized dosing, or prefer liquid medication formulations. To support a successful product launch, EVERSANA is currently activating an array of services, including field deployment, data & analytics, and co-pay services. The SUBVENITE(R) launch support is part of EVERSANA and OWP's broader commercialization partnership announced in January 2022. "Market access challenges continue to be the major hurdle for patients looking for new treatment options," said Gregory Skalicky, President, EVERSANA. "Together with OWP Pharmaceuticals, we're removing barriers and helping patients find new hope." OWP Pharmaceutical's commitment to innovation for patients expands beyond the United States. Since its founding in 2014, the company has developed a unique partnership with the ROW Foundation to support humanitarian efforts for people worldwide with epilepsy. As innovative new solutions like SUBVENITE become available, OWP is committed to ensuring it reaches patients in need, as nearly 80% of people with epilepsy live in underdeveloped countries, and about 75% of them do not have access to a treatment option. "Working with EVERSANA to support commercialization efforts in the U.S. is an important milestone for patients," said Scott Boyer, Founder and President, OWP Pharmaceuticals. "But our vision continues to be much larger, that every epilepsy patient globally one day might have access through OWP Pharma and ROW Foundation, the Pharmaceutical Social Enterprise(R). To learn more about OWP Pharmaceuticals, visit www.owppharma.com. About EVERSANA EVERSANA(R) is a leading independent provider of global services to the life sciences industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X. About OWP Pharmaceuticals OWP Pharmaceuticals is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and commercializing novel oral liquid formulations. Based in Lisle, IL, OWP is committed to advancing therapies in neurology and psychiatry, with a mission to bring meaningful innovations to patients. Through its partnership with the ROW Foundation, OWP also supports global initiatives to improve epilepsy care and education in underserved communities worldwide. For EVERSANA Matt Braun Vice President, Corporate Communications [email protected] SOURCE EVERSANA; OWP Pharmaceuticals

Arkansas Democrat-Gazette
Aug 27th, 2025
Eversana acquires Waltz Health

Eversana, a company that helps drugmakers sell their medicines, has acquired a smaller firm called Waltz Health that helps employers and health insurance companies purchase cheaper drugs, in a bid to build an alternative to traditional pharmacy benefits middlemen in the U.S.

PharmaLive
Aug 26th, 2025
EVERSANA Merges with Waltz Health

EVERSANA merges with Waltz Health.